药物信息为TALWIN INJECTION PENTAZOCINE LACTATE INJECTION, USP (Hospira, Inc.): OVERDOSAGE
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- CONTRAINDICATION
- WARNINGS
- PRECAUTIONS
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- OVERDOSAGE
- HOW SUPPLIED
- Diseases/Conditions Related to TALWIN INJECTION PENTAZOCINE LACTATE INJECTION, USP (Hospira, Inc.)
- 外部链接相关的TALWIN INJECTION PENTAZOCINE LACTATE INJECTION, USP (Hospira, Inc.)
Manifestations: Clinical experience with TALWIN overdosage has been insufficient to define the signs of this condition.
Treatment: Oxygen, intravenous fluids, vasopressors, and other supportive measures should be employed as indicated. Assisted or controlled ventilation should also be considered. For respiratory depression due to overdosage or unusual sensitivity to TALWIN, parenteral naloxone is a specific and effective antagonist.
- Drug Information Provided by National Library of Medicine (NLM).
